<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian Journal of Neurosurgery</title>
<title_fa>مجله جراحی مغز و اعصاب ایران</title_fa>
<short_title>Iran J Neurosurg</short_title>
<subject>Medical Sciences</subject>
<web_url>http://irjns.org</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2423-6497</journal_id_issn>
<journal_id_issn_online>2423-6829</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.32598/irjns</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1399</year>
	<month>1</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2020</year>
	<month>4</month>
	<day>1</day>
</pubdate>
<volume>6</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Three-Year Survival Rate in All Kinds of Glioma Tumors in One Institution, Iran, 2001-2010</title>
	<subject_fa></subject_fa>
	<subject>Brain Tumors</subject>
	<content_type_fa></content_type_fa>
	<content_type>Research</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;strong&gt;Background and Aim&lt;/strong&gt;: The survival rate of brain tumors has not yet been reported in Iran. The purpose of this study, given the lack of such information, was to evaluate the 3-year survival rate in patients with all kinds of glioma tumors.&lt;br&gt;
&lt;strong&gt;Methods and Materials/Patients&lt;/strong&gt;: This study was descriptive and retrospective, including 222 patients who had been diagnosed clinically with one type of glioma tumor and admitted to Al-Zahra hospital, Isfahan, Iran during 2001-2010. All patients (for minors, their parents) were contacted by phone. They were asked about the 3-year survival rate following their tumor resection surgery. Data such as patient&amp;rsquo;s age on admission, gender, histological diagnosis of tumor, and treatment regimen (surgical/non-surgical, radiation, and/or chemotherapy) were collected from medical records. The 3-year survival rate and frequency of each tumor based on age and gender were measured.&lt;br&gt;
&lt;strong&gt;Results&lt;/strong&gt;: The 3-year survival rates for Glioblastoma Multiform (GBM) and anaplastic astrocytoma were 8.7% and 0%, respectively following surgery and chemo-radiation. These tumors were categorized as high-grade glioma with poor prognosis. The 3-year survival rate for diffuse astrocytoma, low-grade oligodendroglioma, low-grade ependymoma, and pilocytic astrocytoma following surgery and radiation were 100%, 95.2%, 100%, and 100%, respectively. These tumors were categorized as low-grade glioma, which has a good prognosis.&lt;br&gt;
&lt;strong&gt;Conclusion&lt;/strong&gt;: In this study, the 3-year survival rate in patients with low-grade glioma following surgery and radiation was almost 100%. In contrast, the 3-year survival rate in patients with highgrade glioma following surgery and chemo-radiation was almost 0%.</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Three-year survival rate, High-grade glioma, Low-grade glioma, Iran</keyword>
	<start_page>67</start_page>
	<end_page>72</end_page>
	<web_url>http://irjns.org/browse.php?a_code=A-10-272-2&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Masih</first_name>
	<middle_name></middle_name>
	<last_name>Rezaee</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>Masih.rezaee2009@gmail.com</email>
	<code>10031947532846005553</code>
	<orcid>10031947532846005553</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Division of Pulmonary, Allergy and Sleep Medicine, Department of Internal Medicine, Mayo Clinic, Jacksonville, Florida, Unites States.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Bahram</first_name>
	<middle_name></middle_name>
	<last_name>Amin Mansour</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>bamin2961@gmail.com</email>
	<code>10031947532846005554</code>
	<orcid>10031947532846005554</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Department of Neurosurgery, Al-Zahra Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
